Target intelligence / Profile preview

RNA binding motif protein 11 (RBM11)

Target
RBM11
Molecular classification
RNA-binding protein, Splicing factor, RRM-containing protein (contains an RNA recognition motif)
01

Overview

RNA binding motif protein 11 (RBM11) is a nuclear, tissue-specific RNA-binding protein that regulates alternative splicing primarily in the brain, cerebellum, testis, and, to a lesser extent, kidney[2][3][4]. It contains an amino-terminal RNA recognition motif (RRM) responsible for RNA binding, and a carboxyl-terminal region that allows nuclear localization and homodimerization[2][3]. RBM11 modulates selection of 5' splice sites by binding to specific RNA sequences (such as in BCL-X exon 2), antagonizing the activity of SR proteins like SRSF1, and is enriched in nuclear "splicing speckles"[2][3][4]. It affects differentiation events during neuronal and germ cell development and exhibits dynamic intra-nuclear localization in response to transcriptional activity or cellular stress[2][3]. Aberrant expression or function of RBM11 may contribute to disease, including cancer, by altering splicing events critical to cell fate[1][4].

Other names
Splicing regulator RBM11RNA-binding motif protein 11Putative RNA-binding protein 11RBM11 (most common short form)
02

Mechanism of action

Not established; since no drugs directly target RBM11, there are no confirmed mechanisms of action

03

Biological functions

Regulation of alternative mRNA splicing via the spliceosomeModulation of 5' splice site selectionPoly(U) RNA bindingHomodimerizationCellular response to oxidative stressRegulation of differentiation in neurons and germ cells
04

Disease associations

Cancer (through aberrant splicing regulation influencing cell proliferation, migration, and apoptosis)Pancreatic serous cystic neoplasmPotential regulatory roles in neuronal and germ cell differentiation-related diseases
05

Safety considerations

None reported for direct targeting.Since RBM11 is involved in tissue-specific alternative splicing, theoretical concerns exist about off-target effects and impact on normal neuronal and germ cell differentiation, but this has not been documented clinically

Beyond the preview

Go deeper on RNA binding motif protein 11 (RBM11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA binding motif protein 11 (RBM11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call